DermaRite Industries, LLC, a New Jersey-based manufacturer, is recalling several hand soap and antiseptic products due to contamination with a harmful bacteria. The recall affects products including DermaKleen antiseptic lotion soap, KleenFoam antibacterial foam soap, DermaSarra external analgesic, and PeriGiene antiseptic cleanser. These items were distributed throughout the United States and Puerto Rico.

The affected products come in various sizes, including 1,000-milliliter and 800-milliliter containers for the DermaKleen and KleenFoam soaps, and 7.5-ounce sizes for the DermaSarra and PeriGiene products. The expiration dates for these items range from July 2025 to February 2027. A complete list of the affected lot and reorder numbers is available through the company.

The recall was announced on August 8 and has been posted on the U.S. Food and Drug Administration's website. DermaRite reported that the products are contaminated with Burkholderia cepacia, a bacteria that can lead to serious infections, particularly in individuals with weakened immune systems.

"The contaminated products may be used by immunosuppressed individuals or by people attending to immunosuppressed individuals," the company stated. It added that while healthy individuals with minor skin lesions may experience local infections, those who are immunocompromised could face severe complications, including life-threatening sepsis.

According to the Centers for Disease Control and Prevention, Burkholderia cepacia can spread through soil, water, contaminated surfaces, and person-to-person contact. Infections may not always present symptoms, but when they do, individuals might experience respiratory issues, fever, or fatigue. Those with chronic lung conditions, such as cystic fibrosis, are particularly at risk.

DermaRite has informed its distributors and customers to check their inventory and dispose of any recalled products according to their facility's procedures. The company has not received reports of adverse reactions related to the recall. However, it advises anyone experiencing symptoms after using the products to consult a healthcare provider and report any adverse reactions to the FDA's MedWatch Adverse Event Reporting program.

Customers seeking more information about the recall can contact DermaRite at (973) 569-9000, extension 104, during business hours or via email.